0001213900-19-016191.txt : 20190816 0001213900-19-016191.hdr.sgml : 20190816 20190816164556 ACCESSION NUMBER: 0001213900-19-016191 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190816 DATE AS OF CHANGE: 20190816 EFFECTIVENESS DATE: 20190816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-346819 FILM NUMBER: 191033955 BUSINESS ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 D 1 primary_doc.xml X0708 D LIVE 0001766140 Unicycive Therapeutics, Inc. 5150 EL CAMINO REAL, SUITE #A-32 LOS ALTOS CA CALIFORNIA 94022 650-384-0642 DELAWARE None None Corporation true 2016 Shalabh Gupta 5150 El Camino Real, Suite #A-32 Los Altos CA CALIFORNIA 94022 Executive Officer Sandeep Laumas 5150 El Camino Real, Suite #A-32 Los Altos CA CALIFORNIA 94022 Director John Ryan 5150 El Camino Real, Suite #A-32 Los Altos CA CALIFORNIA 94022 Director Biotechnology Decline to Disclose 06b false 2019-03-12 false true false 50000 526950 526950 0 false 9 0 0 0 false Unicycive Therapeutics, Inc. /s/ Shalabh Gupta Shalabh Gupta CEO 2019-08-16